Asia-Pacific Breast Cancer Diagnostics Market

2023-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 18-Country Database and Analysis, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities

This new 18-country report from is available by country, market segment, section, individual marker, and can be customized to specific information needs and budget.
This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years.
The report provides granular market segmentation analysis and forecasts for major breast cancer markers; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current assays and instrumentation; evaluates emerging technologies; and offers specific opportunities and growth strategies for suppliers.

Rationale
The breast cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide breast cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam

Business Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Supplier Shares, Sales and Volume Forecasts
- Sales and market shares of major suppliers
- Five-year test volume and sales forecasts by assays

Instrumentation Review
- Analysis of major analyzers used for breast cancer testing

Technology Assessment
- Assessment of latest technologies and their potential applications for breast cancer diagnostic testing
- Review of competing/complementing technologies
- Companies, universities and research centers developing new breast cancer diagnostic tests and detection technologies

Competitive Strategies
- Strategic assessments of major suppliers and start-up firms developing innovative breast cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
- The companies analyzed in the report include:
Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Fujirebio, Fujifilm Wako, Grifols, Hologic, Leica Biosystems, PerkinElmer, QiagenOrtho, Roche, Siemens Healthineers, Takara Bio, Thermo Fisher, and others.

I. Introduction

II. Worldwide Market Overview

III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview
A. Breast Cancer Statistics and Etiology
B. Breast Cancer Diagnostic Tests
1. CEA
2. CA 15-3
3. CA 27.29
4. CA 125
5. Estrogen Receptor
6. HER2
7. Polypeptide-Specific Antigen
8. Progesterone Receptor
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
E. Personal Testing

VIII. Asia-Pacific Country Market Analyses: Breast Cancer Diagnostics Market Test
Volume and Sales Forecasts for 18 Countries:
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar,
New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam


IX. Competitive Profiles
The report provides strategic assessments of over 30 cancer diagnostics market players and
start-up companies with innovative technologies and products, including:
- Abbott
- Affymetrix
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Danaher/Beckman Coulter/Cepheid
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujifilm Wako
- Fujirebio
- Grifols
- Hologic
- Leica Biosystems
- Qiagen
- QuidelOrtho
- Roche
- Siemens Healthineers
- Takara Bio
- Thermo Fisher

List Of Tables

Major Companies Developing or
Marketing CA 15-3 Tests
Major Companies Developing or
Marketing CA 27.29 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing HER2 Tests
Major Companies Developing or
Marketing Polypeptide-Specific Antigen Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Australia Breast Cancer Diagnostic Volume Forecasts by Test
Australia Breast Cancer Diagnostics Sales Forecasts by Test
Australia Breast Cancer Market by Major Supplier
Bangladesh Breast Cancer Diagnostic Volume Forecasts by Test
Bangladesh Breast Cancer Diagnostics Sales Forecasts by Test
Bangladesh Breast Cancer Market by Major Supplier
China Breast Cancer Diagnostic Volume Forecasts by Test
China Breast Cancer Diagnostics Sales Forecasts by Test
China Breast Cancer Market by Major Supplier
Hong Kong Breast Cancer Diagnostic Volume Forecasts by Test
Hong Kong Breast Cancer Diagnostics Sales Forecasts by Test
Hong Kong Breast Cancer Market by Major Supplier
India Breast Cancer Diagnostic Volume Forecasts by Test
India Breast Cancer Diagnostics Sales Forecasts by Test
India Breast Cancer Market by Major Supplier
Indonesia Breast Cancer Diagnostic Volume Forecasts by Test
Indonesia Breast Cancer Diagnostics Sales Forecasts by Test
Indonesia Breast Cancer Market by Major Supplier
Japan Laboratories Performing Breast Cancer Tests by
Market Segment
Japan Hospital Laboratories Performing
Breast Cancer Tests by Bed Size
Japan Commercial/Private Laboratories
Performing Breast Cancer by Annual Test Volume
Japan Total Breast Cancer Test Volume
Forecast by Market Segment
Japan All Market Segments Breast
Cancer Test Volume Forecast
Japan Hospital Laboratories Breast
Cancer Test Volume Forecast by Assay
Japan Commercial/Private Laboratories Breast
Cancer Test Volume Forecast by Assay
Japan Total Breast Cancer Sales by Market Segment
Japan All Market Segments Breast
Cancer Diagnostics Market Forecast by Test
Japan Hospital Laboratories Breast
Cancer Diagnostics Market Forecast by Test
Japan Commercial/Private Laboratories Breast
Cancer Diagnostics Market Forecast by Test
Japan CEA Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan CA 15-3 Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan CA 27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
Japan Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
Japan HER2 Test Volume and Diagnostics Sales
Forecast by Market Segment
Japan Polypeptide-Specific Antigen Test Volume
and Diagnostics Sales Forecast by Market Segment
Japan Progesterone Receptor Test Volume
and Diagnostics Sales Forecast by Market Segment
Japan Breast Cancer Market by Major Supplier
Japan CA 15-3 Testing Market by Major Supplier
Japan CA 27.29 Testing Market by Major Supplier
Japan CA 125 Testing Market by Major Supplier
Malaysia Breast Cancer Diagnostic Volume Forecasts by Test
Malaysia Breast Cancer Diagnostics Sales Forecasts by Test
Malaysia Breast Cancer Market by Major Supplier
Myanmar Breast Cancer Diagnostic Volume Forecasts by Test
Myanmar Breast Cancer Diagnostics Sales Forecasts by Test
Myanmar Breast Cancer Market by Major Supplier
New Zealand Breast Cancer Diagnostic Volume Forecasts by Test
New Zealand Breast Cancer Diagnostics Sales Forecasts by Test
New Zealand Breast Cancer Market by Major Supplier
Pakistan Breast Cancer Diagnostic Volume Forecasts by Test
Pakistan Breast Cancer Diagnostics Sales Forecasts by Test
Pakistan Breast Cancer Market by Major Supplier
Philippines Breast Cancer Diagnostic Volume Forecasts by Test
Philippines Breast Cancer Diagnostic Volume Forecasts by Test
Philippines Breast Cancer Market by Major Supplier
Singapore Breast Cancer Diagnostic Volume Forecasts by Test
Singapore Breast Cancer Diagnostics Sales Forecasts by Test
Singapore Breast Cancer Market by Major Supplier
South Korea Breast Cancer Diagnostic Volume Forecasts by Test
South Korea Breast Cancer Diagnostics Sales Forecasts by Test
South Korea Breast Cancer Market by Major Supplier
Taiwan Breast Cancer Diagnostic Volume Forecasts by Test
Taiwan Breast Cancer Diagnostics Sales Forecasts by Test
Taiwan Breast Cancer Market by Major Supplier
Thailand Breast Cancer Diagnostic Volume Forecasts by Test
Thailand Breast Cancer Diagnostics Sales Forecasts by Test
Thailand Breast Cancer Market by Major Supplier
Turkey Breast Cancer Diagnostic Volume Forecasts by Test
Turkey Breast Cancer Diagnostics Sales Forecasts by Test
Turkey Breast Cancer Market by Major Supplier
Vietnam Breast Cancer Diagnostic Volume Forecasts by Test
Vietnam Breast Cancer Diagnostics Sales Forecasts
by Test Tumor Marker Classification
Vietnam Breast Cancer Market by Major Supplier

Fill The Form For Sample Request

There is no Reviews available